<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-6387QDV4</identifier><date>2016</date><creator>Hanžel, Jurij</creator><creator>Šabovič, Mišo</creator><relation>documents/doc/6/URN_NBN_SI_doc-6387QDV4_001.pdf</relation><relation>documents/doc/6/URN_NBN_SI_doc-6387QDV4_001.txt</relation><format format_type="issue">2/3</format><format format_type="volume">67</format><format format_type="type">article</format><format format_type="extent">str. 134-140</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID">30046759</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-6387QDV4</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">arterijska hipertenzija</subject><subject language_type_id="eng">drug</subject><subject language_type_id="eng">therapy</subject><subject language_type_id="slv">zdravila</subject><subject language_type_id="slv">zdravljenje</subject><title>Novosti v zdravljenju hiperholesterolemije in arterijske hipertenzije</title><title>Recent advances in the treatment of dyslipidaemia and arterial hypertension</title></Record>